| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 25.396 | 28.478 | 27.468 | 27.105 | 26.819 | 33.201 | 45.037 | 48.327 | 44.922 | 37.779 |
| Total Income - EUR | 25.657 | 28.478 | 27.468 | 27.106 | 26.819 | 33.203 | 45.038 | 48.329 | 44.924 | 37.782 |
| Total Expenses - EUR | 6.621 | 10.170 | 12.040 | 15.059 | 15.689 | 22.312 | 20.190 | 32.310 | 47.811 | 38.233 |
| Gross Profit/Loss - EUR | 19.036 | 18.308 | 15.428 | 12.047 | 11.131 | 10.891 | 24.848 | 16.019 | -2.887 | -451 |
| Net Profit/Loss - EUR | 18.267 | 17.739 | 15.153 | 11.778 | 10.862 | 10.559 | 24.407 | 15.608 | -3.337 | -828 |
| Employees | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 3 |
Check the financial reports for the company - Was Biovet Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.125 | 835 | 547 | 291 | 22 | 0 | 0 | 0 | 25.161 | 21.716 |
| Current Assets | 40.023 | 34.533 | 31.742 | 35.658 | 39.545 | 38.041 | 51.606 | 54.457 | 4.705 | 6.260 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 642 | 2.444 | 346 | 575 | 476 | 0 |
| Cash | 40.023 | 34.533 | 31.742 | 35.658 | 38.904 | 35.597 | 51.260 | 53.882 | 4.229 | 6.260 |
| Shareholders Funds | 34.683 | 33.987 | 31.127 | 27.459 | 37.790 | 36.976 | 50.238 | 53.024 | 22.496 | 15.511 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.465 | 1.381 | 1.162 | 8.490 | 1.778 | 1.066 | 1.368 | 1.432 | 7.371 | 12.465 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Was Biovet Srl